Eleven Biotherapeutics Inc. (EBIO) Surged 8.52% or 0.07 To Price $0.9 On Wednesday

Eleven Biotherapeutics Inc. (EBIO) surged 8.52% or 0.07 to $0.9. It is approximately 1.25 million shares traded, which is 64.36% compare to the average total volume 1.94 million. The market cap of EBIO is $28.67 million. The 52 week price range is from $0.62 to $2.54. Price of EBIO have changed -8.88% during last week. It have changed 27.46% over last month, -45.19% over last 3 months, -47.13% over last 6 months and -58.29% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EBIO is 0.80. It is -11.11% below current price. The 200-day Moving Averages for EBIO is 1.37. It is 52.22% above current price. The 52-week High is 2.54. It is 182.22% from the current price. The 52-week Low is 0.62. It is -31.11% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of EBIO is 1.04 on 2017-12-15. Short % to float is 5.86%. There are some statistics of EBIO. It is has market cap $28.67 million. The share outstanding is 31.83 million. The average volume is 1.94 million. The percent of top 15 Institution holding is 13.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EBIO is -86.20%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EBIO is -33.48%.


Share this post